Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Calcium antagonists and vasodilatation

T Godfraind1

  • 1Laboratoire de Pharmacologie, Université Catholique de Louvain, Brussels, Belgium.

Pharmacology & Therapeutics
|October 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Calcium channel blockers and tissue remodeling in hypertension].

Bulletin et memoires de l'Academie royale de medecine de Belgique·2002
Same author

Effects of amlodipine and lacidipine on cardiac remodelling and renin production in salt-loaded stroke-prone hypertensive rats.

British journal of pharmacology·2001
Same author

New insights into the therapeutic mechanism of action of calcium channel blockers in salt-dependent hypertension: their interaction with endothelin gene expression.

Journal of cardiovascular pharmacology·2001
Same author

Lacidipine prevents endothelial dysfunction in salt-loaded stroke-prone hypertensive rats.

Hypertension (Dallas, Tex. : 1979)·2001
Same author

Carvedilol and lacidipine prevent cardiac hypertrophy and endothelin-1 gene overexpression after aortic banding.

Hypertension (Dallas, Tex. : 1979)·1999
Same author

Effect of nitro-L-arginine on electrical and mechanical responses to acetylcholine in the superior mesenteric artery from stroke-prone hypertensive rat.

British journal of pharmacology·1999

Calcium antagonists, used for cardiovascular diseases, work by blocking L-type calcium channels to inhibit smooth muscle contraction. This review reveals their therapeutic actions are more complex than simple vasodilation, highlighting distinct pharmacological profiles.

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Physiology

Background:

  • Calcium antagonists are diverse agents targeting voltage-operated calcium channels (L-type).
  • These drugs are clinically applied in hypertension, angina pectoris, and investigated for heart failure and atherosclerosis.
  • Current understanding attributes their therapeutic effects primarily to vasodilation.

Purpose of the Study:

  • To critically evaluate the therapeutic mechanisms of calcium antagonists.
  • To challenge the oversimplified view of vasodilation as the sole action.
  • To demonstrate the distinct pharmacological properties among different calcium antagonists.

Main Methods:

  • Review of existing scientific literature on calcium antagonists.
  • Analysis of pharmacological data and clinical studies.

Related Experiment Videos

  • Comparative assessment of different classes of calcium antagonists.

    • Main Results:

    • Calcium antagonists exhibit varied mechanisms beyond simple vasodilation.
    • Their therapeutic effects are influenced by tissue-specific actions and channel interactions.
    • Significant pharmacological differences exist between various calcium antagonist agents.

    Conclusions:

    • The therapeutic actions of calcium antagonists are multifaceted and not solely explained by vasodilation.
    • Understanding the distinct pharmacological profiles is crucial for optimizing their clinical use.
    • Further research is warranted to fully elucidate the complex roles of calcium antagonists in cardiovascular health.